PYRANTEL PAMOATE- pyrantel pamoate suspension 
Aurora Pharmaceutical LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

ORAL-PRO™
Pyrantel Pamoate Suspension

Pyrantel Pamoate Suspension is used for the treatment of pinworms.

Drug Facts

Active Ingredient

Each 1 mL contains: Pyrantel base (as Pyrantel Pamoate) 50 mg

Purpose

Pinworm treatment

Uses

For pinworms treatment

Warnings

• Abdominal cramps, nausea, vomiting, diarhea, headache or dizziness sometimes occur after taking this drug. If any of these conditions persist, consult a physician.
• Keep this and all mediactions out of reach of children.
• In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.

Do not use

• If you are pregnant or have liver disease, do not take this product unless directed by a physician.

When using this product

  • Shake well before use.

Directions

• Adults and children 2 years to 12 years of age may take this product. Take the dosage in Table 1 according to the body weight of the individual treated. Do not exceed 4 teaspoonful (20.0 mL) of Pyrantel Pamoate Suspension.

• Carefully read additional product information (located on the inside of label) before using this medication. Take only according to directions and do not exceed the recommended dosage unless directed by a physician. Medication should only be taken one time as a single dose, do not repeat treatment unless directed by a physician. When one individual in a household has pinworms, the entire household should be treated unless otherwise advised. See WARNINGS. If any worms other than pinworms are present before or after treatment, consult a physician. If any symptoms or pinworms are still present after treatment, consult a physician.

• This product can be taken any time of day, with or without meals. It may be taken alone or with milk or juice. Use of a laxative is not necessary prior to, during or after medication.

Dosage Information

Each mL of Pyrantel Pamoate Suspension contains the equivalent of 50 mg of Pyrantel Base (as Pyrantel Pamoate).

Table 1.

Pyrantel Pamoate Suspension Dosage Guide

 Less than25 lbs.

(11 Kg) or under 2 years old

Do not use unless

directed by a physician 

 25-37 lbs. (11-16 kg) 1/2 teaspoonful (2.5 mL)
 38-62 lbs. (17-28 kg) 1 teaspoonful (5.0 mL)
 63-87 lbs. (29-39 kg) 1 1/2 teaspoonful (7.5 mL)
 88-112 lbs. (40-50 kg) 2 teaspoonful (10.0 mL)
 113-137 lbs. (51-62 kg) 2 1/2 teaspoonful (12.5 mL)
 138-162 lbs. (63-73 kg) 3 teaspoonful (15.0 mL)
 163-187 lbs. (74-84 kg) 3 1/2 teaspoonful (17.5 mL)
 188 lbs. (85 kg and over) 4 teaspoonful (20.0 mL)

Other Information

Store at 20°–25° C (68°–77° F). Excursions permitted between 15°–30° C (59°–86° F). Do not freeze.

Inactive Ingredients

Citric acid, potassium sorbate, purified water, propylene glycol, sodium benzoate, sucralose, vanilla custard flavor, xanthan gum.

Questions? 1-888-215-1256

PPEL BACK AT CORNER FOR IMPORTANT PRODUCT INFORMATION

MANUFACTURED IN THE USA

TAKE TIME OBSERVE LABEL DIRECTIONS

Do not use if the seal is open or broken

REORDER NO: 21013

MANUFACTURED BY:

Aurora Pharmaceutical, LLC

NORTHFIELD, MINNESOTA 55057

888-215-1256

www.aurorapharmaceutical.com

IN 50-1227 04/2013

Keep Out of Reach of Children

PRINCIPAL DISPLAY PANEL - 946 mL Bottle Label

NDC 51072-065-00

ORAL-PRO™

Pyrantel Pamoate

Suspension

Pinworm Treatment

50mg/mL Pyrantel Base

Pharmacy Bulk Pack

Keep Out of Reach of Children

32 fl. oz. (946 mL)

image description

PYRANTEL PAMOATE 
pyrantel pamoate suspension
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51072-065
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PYRANTEL PAMOATE (UNII: 81BK194Z5M) (PYRANTEL - UNII:4QIH0N49E7) PYRANTEL5 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
WATER (UNII: 059QF0KO0R)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
XANTHAN GUM (UNII: TTV12P4NEE)  
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
Product Characteristics
Color    Score    
ShapeSize
FlavorVANILLA (Custard) Imprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:51072-065-00946 mL in 1 BOTTLE; Type 0: Not a Combination Product04/19/201309/11/2015
2NDC:51072-065-16473 mL in 1 BOTTLE; Type 0: Not a Combination Product04/19/201309/11/2015
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart357B04/19/201309/11/2015
Labeler - Aurora Pharmaceutical LLC (832848639)
Establishment
NameAddressID/FEIBusiness Operations
Aurora Pharmaceutical LLC832848639manufacture(51072-065)

Revised: 1/2017
 
Aurora Pharmaceutical LLC